Probiotic bacteria are beneficial microorganisms that, when consumed in adequate amounts, confer health benefits to the host. Commonly found in fermented foods and dietary supplements, these bacteria primarily belong to the genera Lactobacillus, Bifidobacterium, and others. Probiotics promote a balanced microbial community in the gut, influencing digestion, nutrient absorption, and immune function. Probiotic supplementation has been associated with various health benefits, including improved gut health, enhanced immune response, and the alleviation of gastrointestinal issues such as irritable bowel syndrome. Additionally, probiotics may contribute to the synthesis of certain vitamins and the production of bioactive compounds with anti-inflammatory properties. Research explores the specific strains and dosages of probiotics for different health conditions, optimizing their therapeutic potential. Probiotic-rich foods like yogurt, kefir, and sauerkraut, along with probiotic supplements, provide convenient ways to incorporate these beneficial bacteria into one's diet, promoting overall well-being and gut health.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom